H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 200 Citations 257,321 3,307 World Ranking 61 National Ranking 9

Research.com Recognitions

Awards & Achievements

Fellow of the American College of Cardiology (ACC)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cardiology
  • Atrial fibrillation

His scientific interests lie mostly in Internal medicine, Atrial fibrillation, Cardiology, Stroke and Warfarin. His studies in Internal medicine integrate themes in fields like Endocrinology and Surgery. His work carried out in the field of Atrial fibrillation brings together such families of science as Hazard ratio, Anesthesia, Risk assessment and Antithrombotic.

In his study, Vascular disease and Fibrinogen is strongly linked to Von Willebrand factor, which falls under the umbrella field of Cardiology. His research integrates issues of Vitamin K antagonist, Anticoagulant, Apixaban, Aspirin and Risk factor in his study of Stroke. His Warfarin research incorporates themes from Lower risk and Physical therapy.

His most cited work include:

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (9345 citations)
  • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. (4091 citations)
  • 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (3899 citations)

What are the main themes of his work throughout his whole career to date?

Gregory Y.H. Lip mainly focuses on Internal medicine, Atrial fibrillation, Cardiology, Stroke and Warfarin. His study on Heart failure, Hazard ratio and Myocardial infarction is often connected to In patient as part of broader study in Internal medicine. His study looks at the relationship between Atrial fibrillation and fields such as Intensive care medicine, as well as how they intersect with chemical problems.

Gregory Y.H. Lip has researched Cardiology in several fields, including Thrombosis, Surgery and Blood pressure. His Stroke study combines topics from a wide range of disciplines, such as Diabetes mellitus, Aspirin, Risk assessment and Risk factor. Gregory Y.H. Lip has included themes like Anticoagulant, Anesthesia and Randomized controlled trial in his Warfarin study.

He most often published in these fields:

  • Internal medicine (94.69%)
  • Atrial fibrillation (83.90%)
  • Cardiology (64.78%)

What were the highlights of his more recent work (between 2019-2021)?

  • Atrial fibrillation (83.90%)
  • Internal medicine (94.69%)
  • Cardiology (64.78%)

In recent papers he was focusing on the following fields of study:

Gregory Y.H. Lip mainly investigates Atrial fibrillation, Internal medicine, Cardiology, Stroke and In patient. His Atrial fibrillation course of study focuses on Intensive care medicine and MEDLINE. His research in Internal medicine tackles topics such as Diabetes mellitus which are related to areas like Kidney disease.

His Cardiology study combines topics in areas such as Blood pressure and Risk factor. The Stroke study combines topics in areas such as Adverse effect, Randomized controlled trial, Myocardial infarction and Emergency medicine. Gregory Y.H. Lip interconnects Proportional hazards model and Cohort study in the investigation of issues within Hazard ratio.

Between 2019 and 2021, his most popular works were:

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
  • 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) (424 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Cardiology

Internal medicine, Atrial fibrillation, Stroke, Cardiology and Hazard ratio are his primary areas of study. Gregory Y.H. Lip undertakes multidisciplinary investigations into Internal medicine and In patient in his work. His study in Atrial fibrillation is interdisciplinary in nature, drawing from both Lower risk, Heart failure and Intensive care medicine.

His Stroke study incorporates themes from Odds ratio, Adverse effect, Risk assessment and Comorbidity. His studies deal with areas such as Diabetes mellitus and Risk factor as well as Cardiology. His Hazard ratio research is multidisciplinary, incorporating elements of Integrated care and COPD.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno.
European Journal of Heart Failure (2016)

19435 Citations

2007 Guidelines for the management of arterial hypertension

Giuseppe Mancia;Guy De Backer;Anna Dominiczak;Renata Cifkova.
European Heart Journal (2007)

15171 Citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof;Stefano Benussi;Dipak Kotecha;Anders Ahlsson.
Europace (2016)

8635 Citations

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio.
European Heart Journal (2012)

7218 Citations

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Gregory Y. H. Lip;Robby Nieuwlaat;Ron Pisters;Deirdre A. Lane.
Chest (2010)

6607 Citations

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Bryan Williams;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti Rosei.
European Heart Journal (2018)

5146 Citations

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

A. John Camm;Gregory Y.H. Lip.
European Heart Journal (2012)

4255 Citations

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Ron Pisters;Deirdre A. Lane;Robby Nieuwlaat;Cees B. de Vos.
Chest (2010)

4063 Citations

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design

Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
Europace (2012)

3830 Citations

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist.
European Heart Journal (2008)

3660 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Gregory Y.H. Lip

Gunnar H. Gislason

Gunnar H. Gislason

National Heart Foundation of Australia

Publications: 309

Paulus Kirchhof

Paulus Kirchhof

University of Birmingham

Publications: 254

John G.F. Cleland

John G.F. Cleland

National Institutes of Health

Publications: 247

Jonathan P. Piccini

Jonathan P. Piccini

Duke University

Publications: 241

Thomas F. Lüscher

Thomas F. Lüscher

University of Zurich

Publications: 237

Maciej Banach

Maciej Banach

Medical University of Lodz

Publications: 231

Marco Metra

Marco Metra

University of Brescia

Publications: 225

Christian Torp-Pedersen

Christian Torp-Pedersen

Aalborg University

Publications: 224

Dirk J. van Veldhuisen

Dirk J. van Veldhuisen

University Medical Center Groningen

Publications: 206

John J.V. McMurray

John J.V. McMurray

University of Glasgow

Publications: 205

Gerasimos Filippatos

Gerasimos Filippatos

National and Kapodistrian University of Athens

Publications: 201

Piotr Ponikowski

Piotr Ponikowski

Wrocław Medical University

Publications: 185

Renato D. Lopes

Renato D. Lopes

Duke University

Publications: 184

Adriaan A. Voors

Adriaan A. Voors

University Medical Center Groningen

Publications: 183

Lars Køber

Lars Køber

Copenhagen University Hospital

Publications: 183

Something went wrong. Please try again later.